NOW LOADING

Buy, Sell or Hold This US Mid Cap Stock-ASAN

Acrobull UK Advisory Services Ltd.

 

June 062025
NameTickerSector/IndustryMarket CapRisk Factor 

Asana Inc.

ASAN-NYSETechnology$3.464 BillionMedium 
       

 

Asana, Inc., together with its subsidiaries, operates a work management software platform for individuals, team leads, and executives in the United States and internationally.

 

 

Recent Highlights

 

 

  • Recent HighlightsDespite the revenue growth and positive adjusted EPS, Asana's stock experienced a decline of approximately 15% following the announcement. This drop was attributed to concerns over the lower-than-expected NRR and potential challenges in customer retention, particularly in the enterprise and middle-market segments. The company also noted increased buyer scrutiny and elongated decision-making processes, especially regarding software consolidation efforts.

 

  • While the revenue guidance for Q2 is optimistic, the company acknowledged that the NRR may continue to be a headwind in the short term.
First Quarter 2026 Highlights

 

  • Total revenues reached $187.3 million, representing a 9% increase year over year.

 

  • The GAAP operating loss was $43.9 million, or 23% of revenue, improving from a GAAP operating loss of $66.2 million, or 38% of revenue, in the first quarter of fiscal 2025. On a non-GAAP basis, the company reported operating income of $8.1 million (4% of revenue), compared to a non-GAAP operating loss of $15.8 million (9% of revenue) in the same period last year.

 

  • The GAAP net loss was $40.0 million, down from $63.7 million in the first quarter of fiscal 2025. GAAP net loss per share was $0.17, an improvement from $0.28 per share a year ago. On a non-GAAP basis, net income totaled $12.0 million, compared to a non-GAAP net loss of $13.3 million in the prior year. Non-GAAP net income per share was $0.05, up from a non-GAAP net loss per share of $0.06.

 

 

Stock Observation- The company has delivered strong financial performance in the first quarter of 2026 and is anticipated to achieve even better results in the upcoming quarter. Currently, the RSI for the stock stands at 47, indicating that it is nearing oversold conditions.

 

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

 

 

Stock Observation- The company has reported robust financial growth in the third quarter of 2025 and is expected to report better financial results in the next quarter. The RSI level for the stock is at 42 which shows close to oversold conditions.

 

Risk Involved- Financial performance of the company may have an impact on the company stock performance.

 

 
Considering all the factors and financials of the company Acrobull UK maintains Buy for the stock.

Disclaimer- Though our research is fundamentally and technically based on Acrobull UK only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull UK would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations.

It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull UK is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull UK does not guarantee returns. 

 

Acrobull UK Recommendation Based on Evaluation

 

Current Market Price$14.72 USD
Acrobull RecommendationBuy
Target Price$16.92 USD
RSI Level14 Day RSI 47
Total Shares Outstanding155.76 Million

Shares held by Insiders

Risk Factor

Stop Loss

40.28%

Medium

5%

 

 

Acro Bull UK Logo

© Copyright Acro Bull UK All Rights Reserved 2025

Accepted Payment Modes